⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chloromethane SCHEMBL27866026 | 0.81 | CYP2C19 (0.68) | — | |
| SCHEMBL36990 | 0.81 | CYP2C19 (0.59) | — | |
| SCHEMBL10834211 | 0.81 | CYP2C19 (0.59) | — | |
| Chloroform SCHEMBL29017621 | 0.79 | CYP2C19 (0.58) | — | |
| SCHEMBL4652870 | 0.78 | — | — | |
| SCHEMBL28212838 | 0.78 | — | — | |
| SCHEMBL11477167 | 0.78 | CYP2C19 (0.32) | — | |
| Hydrogen Peroxide SCHEMBL16799548 | 0.78 | CYP2C19 (0.56) | — | |
| Methane SCHEMBL9155165 | 0.78 | CYP2C19 (0.56) | — | |
| SCHEMBL9659709 | 0.78 | CYP2C19 (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4298059-A1 | <SUP2/>? <SUB2/>?3?PROCESS FOR ISOLATING A HYDROCHLORIC, AQUEOUS FECLSOLUTION FROM AN AQUEOUS MULTI-COMPONENT SYSTEM | Bayer Aktiengesellschaft (DE) | 2024-01-03 | — | — | EP | claimed |
| US-20230391634-A1 | METHOD FOR ISOLATING AN AQUEOUS HYDROCHLORIC ACID SOLUTION OF FECL3 FROM AN AQUEOUS MULTI-COMPONENT SYSTEM | BAYER AKTIENGESELLSCHAFT (DE) | 2023-12-07 | — | — | US | claimed |
| CN-116802153-A | For the purpose of introducing FeCl 3 Process for separating aqueous hydrochloric acid from aqueous multicomponent systems | 拜耳公司 | 2023-09-22 | — | — | CN | claimed |
| WO-2022179969-A1 | PROCESS FOR ISOLATING A HYDROCHLORIC, AQUEOUS FECL3 SOLUTION FROM AN AQUEOUS MULTI-COMPONENT SYSTEM | BAYER AKTIENGESELLSCHAFT (DE) | 2022-09-01 | — | — | WO | claimed |
| CN-108238893-A | A kind of synthetic method of pharmaceutical intermediate isovaleric acid | 成都东电艾尔科技有限公司 | 2018-07-03 | — | — | CN | claimed |
| CN-102626401-A | Hydrogel paste and preparation method thereof | FOSHAN BIOURS BIOSCIENCES CO LTD | 2012-08-08 | — | — | CN | claimed |
| US-5475155-A | Reacting an alpha-haloketone with a phenolic-hydroxyl containing compound and a strong protonic acid; neutralization; dehydrohalogenation; dealkylation | THE DOW CHEMICAL COMPANY (US) | 1995-12-12 | — | — | US | claimed |
| WO-1995015301-A1 | PREPARATION OF 4,4'-DIHYDROXY-ALPHA-ALKYLSTILBENES AND 4,4'-DIHYDROXY-ALPHA, ALPHA'-DIALKYLSTILBENES | THE DOW CHEMICAL COMPANY (US) | 1995-06-08 | — | — | WO | claimed |
| US-12110294-B2 | CD73 compounds | GILEAD SCIENCES, INC. (US) | 2024-10-08 | — | — | US | disclosed |
| US-11999732-B2 | P2X3 receptor antagonists | RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA (IT) | 2024-06-04 | — | — | US | disclosed |
| US-20240043427-A1 | CD73 COMPOUNDS | GILEAD SCIENCES, INC. | 2024-02-08 | — | — | US | disclosed |
| CN-112584898-B | P2X 3 Receptor antagonists | 瑞蔻达蒂化学和制药工业股份有限公司 | 2024-01-26 | — | — | CN | disclosed |
| EP-4298059-A1 | <SUP2/>? <SUB2/>?3?PROCESS FOR ISOLATING A HYDROCHLORIC, AQUEOUS FECLSOLUTION FROM AN AQUEOUS MULTI-COMPONENT SYSTEM | Bayer Aktiengesellschaft (DE) | 2024-01-03 | — | — | EP | disclosed |
| US-11840533-B2 | Pyridinone-based epigenetic modifiers and uses thereof | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2023-12-12 | — | — | US | disclosed |
| EP-0633905-A1 | BIODEGRADABLE POLYCARBONATES AND THEIR USE AS DRUG CARRIERS | SANDOZ-ERFINDUNGEN Verwaltungsgesellschaft m.b.H. (AT) | 1995-01-18 | — | — | EP | disclosed |
| WO-1993020126-A1 | BIODEGRADABLE POLYCARBONATES AND THEIR USE AS DRUG CARRIERS | SANDOZ LTD. (CH) | 1993-10-14 | — | — | WO | disclosed |
| US-4898871-A | Pyrrole derivatives and pharmaceutical compositions which contain them as hypnotics and anticonvulsants | RHONE-POULENC SANTE (FR) | 1990-02-06 | — | — | US | disclosed |
| US-4240983-A | HALOGENATION | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-23 | — | — | US | disclosed |
| US-4167571-A | Thiazoline derivatives | RHONE-POULENC INDUSTRIES (FR) | 1979-09-11 | — | — | US | disclosed |
| US-4164579-A | ANTI-ULCER AGENTS | RHONE-POULENC INDUSTRIES (FR) | 1979-08-14 | — | — | US | disclosed |